Our genome analytics platform brings unprecedented insights for meaningful diagnosis.
Our Horizon genome analytics platform is fully automated for whole genome variant interpretations and pathogenicity predictions. The platform provides rapid actionable insights integrating complex phenotype data.
The Horizon platform helps achieve high genetic diagnostic yield and can analyse, interpret and report causal variants in minutes. We use well-curated variant databases and natural language processing (NLP) to understand complex genetic phenotypes.
Automation is at the core of Horizon, as it seamlessly integrates large and phenotypic genome databases with genome variants.
Our variant pathogenicity algorithms validate with high precision using population scaled multi-ethnic clinical genomics datasets.
Horizon platform integrates transcriptomes, proteomes, and other OMICs databases to interpret coded and non-coded genomic variants.
Horizon Genome Analytic Platform Features
The Horizon platform provides rapid precision diagnostic interpretation for reporting genomic variants and providing actionable therapeutic interventive insights for rare genetic diseases.
Our innovative solutions extracts cryptic phenotypic details to integrate large genomic databases for reporting.
Know MoreFor Cancer and Rare Genetic Diseases
Genome Data Processing:
Impact:
Integrate Custom Phenotypic
Database or Software
Lack of ethnic diversity in single-cell transcriptomics
Perhaps one of the most revolutionary next generation sequencing technologies is single-cell (SC) transcriptomics, which was recognized by Nature in 2013 as the method of the year.
Construction of copy number variation landscape
Copy number variations (CNVs) play a critical role in the pathogenesis of neurodevelopmental disorders (NDD) among children.
Horizon’s Quest on Resolving Variant of Uncertain Significance (VUS)
The average human genome encompasses over 4 million variants, impacting a vast array of more than 20,000 protein-coding genes. Unraveling the significance of each variant in human
Read More
Interpretation of Rare Genetic Diseases through Machine Learning-Based Automation
In recent years, the area of genetics has advanced significantly, particularly in the identification of previously unknown and rare disorders. However, the intricacy and quantity of genomic
Read More
Watch our Recent Webinar on Clinical Genetic Testing
To discuss the impact of genetic tests in the clinic, we have Dr. Marc Woodburry-Smith who is a globally renowned neuropsychiatrist and Senior Lecturer at Bioscience Institute
Read MoreWe care about the protection of your data.
Associate Professor,
College of Medicine,
MBRU, Dubai
Founder and CEO,
GenomeArc Inc.
Toronto, Canada
Senior Lecturer,
Biosciences Institute, Newcastle University,
Newcastle Upon Tyne, UK
Associate Professor,
College of Medicine,
Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai
Professor of Medicine,
Faculty of Medicine,
Memorial University, Canada
Director,
Institute of Physiology, Charité - Universitätsmedizin Berlin, Germany
Professor, Associate Scientist,
University of Toronto, Canada
We are a team of geneticist, clinicians, bioinformaticians, software engineers, and ethicists, committed to solving genetic diseases, to advance science and benefit humanity. Our research driven approach is helping us constantly updating and solving the most complex problems in genomic medicine.!
"As a scientist specializing in genomic variant interpretation, I find most platforms have steep learning curves and fragmented toolsets that require piecing together various algorithms and databases to identify disease-relevant variants. Horizon has completely transformed my workflow - its comprehensive suite of analysis tools integrated with expert-curated clinical variant databases enables me to go seamlessly to identify biologically significant and clinically actionable findings. With its rapid and clinically focused genomic analysis capabilities, Horizon is my go-to platform for accelerating variant discovery and delivering insights into precision medicine."
"Horizon is a powerful whole genome analytics platform which offers rapid analysis of both chromosomal microarray and whole genome sequencing data. It can identify and classify disease relevant variants within a short time as well as it provides the significant findings in a structured report. It is user friendly interface for which no bioinformatics expertise is required. As a user of Horizon, I wish for its immense success in recent precision medicine era."
We have global teams supporting customers worldwide and we are headquartered in the wonderful city of Mississauga, Ontario.
GenomeArc Inc. 55 Village Centre Place, Mississauga, ON, L4Z 1V9, Canada
